The stock of Synaptogenix Inc (SNPX) has gone up by 53.94% for the week, with a 54.32% rise in the past month and a 27.93% rise in the past quarter. The volatility ratio for the week is 26.73%, and the volatility levels for the past 30 days are 14.51% for SNPX. The simple moving average for the past 20 days is 30.81% for SNPX’s stock, with a 27.62% simple moving average for the past 200 days.
Is It Worth Investing in Synaptogenix Inc (NASDAQ: SNPX) Right Now?
The 36-month beta value for SNPX is also noteworthy at 1.41. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for SNPX is 1.36M, and at present, short sellers hold a 0.83% of that float. The average trading volume of SNPX on June 16, 2025 was 798.81K shares.
SNPX) stock’s latest price update
Synaptogenix Inc (NASDAQ: SNPX)’s stock price has gone decline by -23.66 in comparison to its previous close of 4.86, however, the company has experienced a 53.94% increase in its stock price over the last five trading days. prnewswire.com reported 2025-06-09 that Singular focus on Bittensor (TAO), the leading AI token by adoption and market capitalization James Altucher to lead TAO token strategy initiatives Planned initial acquisition of $10 million in TAO equates to over two times the Company’s current market capitalization; total acquisition target of $100 million NEW YORK, June 9, 2025 /PRNewswire/ — Synaptogenix, Inc. (Nasdaq: SNPX) (“Synaptogenix” or the “Company”) today announced its launch of a differentiated cryptocurrency treasury strategy focused exclusively on the artificial intelligence (AI) crypto token “TAO,” which is currently the top AI token by market capitalization and adoption. Well-known cryptocurrency and AI expert James Altucher will lead a TAO-based revenue generation strategy targeting staking yield and token appreciation.
SNPX Trading at 48.27% from the 50-Day Moving Average
After a stumble in the market that brought SNPX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -32.79% of loss for the given period.
Stock Fundamentals for SNPX
The total capital return value is set at -0.34. Equity return is now at value -89.46, with -54.45 for asset returns.
Currently, EBITDA for the company is -12.76 million with net debt to EBITDA at 2.9. The liquidity ratio also appears to be rather interesting for investors as it stands at 72.71.
Conclusion
In summary, Synaptogenix Inc (SNPX) has had a better performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
